April 06, 2017
Mylan Inc., Sandoz Inc. and Taro Pharmaceuticals USA Inc. conspired to fix the price of generic clomipramine hydrochloride, a medication used to treat obsessive compulsive disorder, the Philadelphia Federation of Teachers Health and Welfare Fund alleged in a proposed class action Thursday in Pennsylvania federal court.